Literature DB >> 22437193

[Clinically relevant pharmacokinetic drug interactions in the intensive care unit: an overview].

W Kämmerer1.   

Abstract

Critically ill patients in the intensive care unit (ICU) are predisposed to pharmacokinetic drug interactions because of the complexity of the drug regimens received in the intensive care setting. Drugs may affect the absorption, distribution, metabolism and/or elimination of an object drug and consequently alter the intended pharmacologic response and potentially lead to an adverse event. The paper presents an overview of pharmacokinetic drug-drug interactions which can occur with commonly used drugs in the ICU and outlines the underlying types and mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22437193     DOI: 10.1007/s00063-012-0099-9

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  18 in total

Review 1.  [Cytochrome P450 enzymes and their role in drug interactions].

Authors:  C Papp-Jámbor; U Jaschinski; H Forst
Journal:  Anaesthesist       Date:  2002-01       Impact factor: 1.041

Review 2.  Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations.

Authors:  John Papadopoulos; Pamela L Smithburger
Journal:  Crit Care Med       Date:  2010-06       Impact factor: 7.598

Review 3.  Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

Authors:  Aline H Saad; Daryl D DePestel; Peggy L Carver
Journal:  Pharmacotherapy       Date:  2006-12       Impact factor: 4.705

4.  Drug interactions.

Authors:  K T Olkkola; J Ahonen
Journal:  Curr Opin Anaesthesiol       Date:  2001-08       Impact factor: 2.706

Review 5.  Updates on cytochrome P450-mediated cardiovascular drug interactions.

Authors:  Judy W M Cheng; William H Frishman; Wilbert S Aronow
Journal:  Am J Ther       Date:  2009 Mar-Apr       Impact factor: 2.688

Review 6.  Clinical impact of drug-drug interactions with systemic azole antifungals.

Authors:  David W Bates; D Tony Yu
Journal:  Drugs Today (Barc)       Date:  2003-10       Impact factor: 2.245

Review 7.  Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes.

Authors:  Fawzy A Elbarbry; Travis Marfleet; Ahmed S Shoker
Journal:  Transplantation       Date:  2008-05-15       Impact factor: 4.939

8.  Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure.

Authors:  Joseph A Carcillo; Lesley Doughty; Danny Kofos; Reginald F Frye; Sandra S Kaplan; Howell Sasser; Gilbert J Burckart
Journal:  Intensive Care Med       Date:  2003-04-16       Impact factor: 17.440

Review 9.  Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring.

Authors:  Shu-Feng Zhou; Charlie Changli Xue; Xue-Qing Yu; Chunguang Li; Guangji Wang
Journal:  Ther Drug Monit       Date:  2007-12       Impact factor: 3.681

10.  Altered theophylline pharmacokinetics during acute respiratory viral illness.

Authors:  K C Chang; T D Bell; B A Lauer; H Chai
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

View more
  2 in total

Review 1.  [Rational use of antibiotics].

Authors:  P Walger
Journal:  Internist (Berl)       Date:  2016-06       Impact factor: 0.743

2.  Polypharmacy in the elderly from the clinical toxicologist perspective.

Authors:  H J Heppner; M Christ; M Gosch; W Mühlberg; P Bahrmann; T Bertsch; C Sieber; K Singler
Journal:  Z Gerontol Geriatr       Date:  2012-08       Impact factor: 1.281

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.